Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Enliven Therapeutics, Inc. | 51,000 | reported | 06 Mar 2026 | tx 148+1,169,184−314,128 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Mar 2026 | SALE | Enliven Therapeutics, Inc. | 10,000 | 29.58 USD | |
| 12 Feb 2026 | GRANT_AWARD | Enliven Therapeutics, Inc. | 25,000 | 0.00 USD | |
| 12 Feb 2026 | GRANT_AWARD | Enliven Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 22 Dec 2025 | EXERCISE | Enliven Therapeutics, Inc. | 13,000 | 2.48 USD | |
| 22 Dec 2025 | EXERCISE | Enliven Therapeutics, Inc. | 13,000 | 0.00 USD | deriv |
| 29 Sept 2025 | SALE | Enliven Therapeutics, Inc. | 3,250 | 20.40 USD | |
| 29 Sept 2025 | EXERCISE | Enliven Therapeutics, Inc. | 3,250 | 2.48 USD | |
| 29 Sept 2025 | EXERCISE | Enliven Therapeutics, Inc. | 3,250 | 0.00 USD | deriv |
| 27 Aug 2025 | SALE | Enliven Therapeutics, Inc. | 3,250 | 20.63 USD | |
| 27 Aug 2025 | EXERCISE | Enliven Therapeutics, Inc. | 3,250 | 2.48 USD | |
| 27 Aug 2025 | EXERCISE | Enliven Therapeutics, Inc. | 3,250 | 0.00 USD | deriv |
| 28 Jul 2025 | EXERCISE | Enliven Therapeutics, Inc. | 3,250 | 2.48 USD | |
| 28 Jul 2025 | SALE | Enliven Therapeutics, Inc. | 65 | 21.30 USD | anomaly |
| 28 Jul 2025 | SALE | Enliven Therapeutics, Inc. | 3,185 | 20.45 USD | |
| 28 Jul 2025 | EXERCISE | Enliven Therapeutics, Inc. | 3,250 | 0.00 USD | deriv |
| 10 Jul 2025 | EXERCISE | Enliven Therapeutics, Inc. | 1,000 | 2.48 USD | |
| 10 Jul 2025 | SALE | Enliven Therapeutics, Inc. | 1,000 | 22.66 USD | |
| 10 Jul 2025 | EXERCISE | Enliven Therapeutics, Inc. | 1,000 | 0.00 USD | deriv |
| 27 Jun 2025 | EXERCISE | Enliven Therapeutics, Inc. | 3,250 | 2.48 USD | |
| 27 Jun 2025 | SALE | Enliven Therapeutics, Inc. | 3,052 | 20.86 USD | |
| 27 Jun 2025 | SALE | Enliven Therapeutics, Inc. | 198 | 21.66 USD | |
| 27 Jun 2025 | EXERCISE | Enliven Therapeutics, Inc. | 3,250 | 0.00 USD | deriv |
| 13 Jun 2025 | SALE | Enliven Therapeutics, Inc. | 3,000 | 22.55 USD | |
| 13 Jun 2025 | EXERCISE | Enliven Therapeutics, Inc. | 3,000 | 2.48 USD | |
| 13 Jun 2025 | EXERCISE | Enliven Therapeutics, Inc. | 3,000 | 0.00 USD | deriv |